| 产品分类 |
货号 |
产品名称 |
靶点 |
| 双抗 |
CHBA012 |
Anti-PD-L1 & TGF-Beta Reference Antibody (Tqb2858) |
B7-H1 / PD-L1 / CD274,TGFb1 |
| 双抗 |
CHBA023 |
Anti-4-1BB & PD-L1 Reference Antibody (Enristomig) |
B7-H1 / PD-L1 / CD274,TNFRSF9 / 4-1BB / CD137 |
| 双抗 |
CHBA057 |
Anti-4-1BB & PD-L1 Reference Antibody (Acasunlimab) |
B7-H1 / PD-L1 / CD274,TNFRSF9 / 4-1BB / CD137 |
| 双抗 |
CHBA003 |
Anti-PD-L1 & VEGF Reference Antibody (Pm8002） |
B7-H1 / PD-L1 / CD274,VEGF |
| 双抗 |
CHBA011 |
Anti-PD-L1 & VEGF Reference Antibody (Sotiburafusp alfa） |
B7-H1 / PD-L1 / CD274,VEGF |
| 双抗 |
CHBA047 |
Anti-B7-H4 & CD3 Reference Antibody (Gen1047) |
B7-H4 / VTCN1,CD3 |
| 双抗 |
CHBA068 |
Anti-CD19 & CD3 Reference Antibody (Blinatumomab) |
CD19,CD3 |
| 双抗 |
CHBA008 |
Anti-CD3 & CD20 Reference Antibody (Epcoritamab) |
CD20,CD3 |
| 双抗 |
CHBA015 |
Anti-CD20 & CD3 Reference Antibody (Glofitamab) |
CD20,CD3 |
| 双抗 |
CHBA045 |
Anti-CD20 & CD3 Reference Antibody (Odronextamab) |
CD20,CD3 |
| 双抗 |
CHBA021 |
Anti-CD20 & CD3e Reference Antibody (Mosunetuzumab) |
CD20,CD3e |
| 双抗 |
CHBA052 |
Anti-CD20 & CD47 Reference Antibody (Amulirafusp alfa) |
CD20,CD47 |
| 双抗 |
CHBA066 |
Anti-CA125 & CD3 Reference Antibody (Ubamatamab) |
CD3,CA125 / MUC16 |
| 双抗 |
CHBA064 |
Anti-CD3 & GD2 Reference Antibody (Nivatrotamab) |
CD3,GD2 |
| 双抗 |
CHBA026 |
Anti-GPRC5D & CD3 Reference Antibody (Talquetamab) |
CD3,GPRC5D / GPC5D |
| 双抗 |
CHBA028 |
Anti-CD79b & Fc-gamma-R2B/CD32b Reference Antibody (Mgd010) |
CD79b,FcgR2b / CD32b |
| 双抗 |
CHBA022 |
Anti-C5 & Serum Albumin Reference Antibody (Gefurulimab) |
Complement C5,Serum Albumin / SA / HSA |
| 双抗 |
CHBA005 |
Anti-CTLA4 & PD-L1 Reference Antibody (Erfonrilimab) |
CTLA-4 / CD152,B7-H1 / PD-L1 / CD274 |
| 双抗 |
CHBA002 |
Anti-PD-1 & CTLA-4 Reference Antibody (Cadonilimab) |
CTLA-4 / CD152,PDCD1 / PD-1 / CD279 |
| 双抗 |
CHBA053 |
Anti-CTLA4 & PD-1 Reference Antibody (Volrustomig) |
CTLA-4 / CD152,PDCD1 / PD-1 / CD279 |
| 双抗 |
CHBA069 |
Anti-CTLA4 & PD-1 Reference Antibody (Vudalimab) |
CTLA-4 / CD152,PDCD1 / PD-1 / CD279 |
| 双抗 |
CHBA072 |
Anti-CD3 & DLL3 Reference Antibody (Tarlatamab) |
DLL3,CD3 |
| 双抗 |
CHBA051 |
Anti-CD3e & DLL3 & Serum Albumin Reference Antibody (Hpn328) |
DLL3,CD3e,Serum Albumin / SA / HSA |
| 双抗 |
CHBA058 |
Anti-DLL4 & VEGF Reference Antibody (Navicixizumab) |
DLL4,VEGF |
| 双抗 |
CHBA073 |
Anti-CD3 & EpCAM Reference Antibody (M701) |
EpCAM / TROP1 / CD326,CD3 |
| 双抗 |
CHBA042 |
Anti-B7-H3 & EGFR Reference Antibody (Ibi-334) |
ERBB1 / EGFR / HER1,B7-H3 / CD276 |
| 双抗 |
CHBA038 |
Anti-CD28 & EGFR Reference Antibody (Regn7075) |
ERBB1 / EGFR / HER1,CD28 |
| 双抗 |
CHBA007 |
Anti-EGFR & HER3 Reference Antibody (Duligotuzumab) |
ERBB1 / EGFR / HER1,ERBB3 / HER3 |
| 双抗 |
CHBA027 |
Anti-EGFR & HER3 Reference Antibody (Izalontamab) |
ERBB1 / EGFR / HER1,ERBB3 / HER3 |
| 双抗 |
CHBA049 |
Anti-EGFR & Fc-gamma-RIIIA Reference Antibody (AFM24) |
ERBB1 / EGFR / HER1,FcgR3a / CD16a |
| 双抗 |
CHBA060 |
Anti-HER2/neu Reference Antibody (Zanidatamab) |
ERBB2 / HER2 / CD340 |
| 双抗 |
CHBA070 |
Anti-HER2/neu & HER3 Reference Antibody (Zenocutuzumab) |
ERBB2 / HER2 / CD340,ERBB3 / HER3 |
| 双抗 |
CHBA039 |
Anti-4-1BB & HER2/neu Reference Antibody (Yh32367) |
ERBB2 / HER2 / CD340,TNFRSF9 / 4-1BB / CD137 |
| 双抗 |
CHBA013 |
Anti-HER3 & IGF-1R Reference Antibody (Istiratumab) |
ERBB3 / HER3,IGF1-R / IGFR1 / CD221 |
| 双抗 |
CHBA063 |
Anti-Factor IX & Factor X Reference Antibody (Emicizumab) |
F9 / Factor IX,Factor X / FXa |
| 双抗 |
CHBA074 |
Anti-CD28 & PSMA Reference Antibody (Nezastomig) |
FOLH1 / PSMA,CD28 |
| 双抗 |
CHBA024 |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Anbenitamab) |
HER2/neu |
| 双抗 |
CHBA031 |
Anti-cMet Reference Antibody (Davutamig) |
HGFR / c-Met |
| 双抗 |
CHBA032 |
Anti-cMet & EGFR Reference Antibody (Emb01) |
HGFR / c-Met,ERBB1 / EGFR / HER1 |
| 双抗 |
CHBA048 |
Anti-cMet & EGFR Reference Antibody (Amivantamab) |
HGFR / c-Met,ERBB1 / EGFR / HER1 |
| 双抗 |
CHBA018 |
Anti-IL-13 & IL-4 Reference Antibody (Romilkimab) |
IL-13,IL-4 |
| 双抗 |
CHBA006 |
Anti-IL-17 & IL-17F & Serum Albumin Reference Antibody (Sonelokimab) |
IL-17 / IL-17A / CTLA-8,IL-17F,Serum Albumin / SA / HSA |
| 双抗 |
CHBA017 |
Anti-IL-18 & IL-1β Reference Antibody (Mas825) |
IL-18,IL-1b |
| 双抗 |
CHBA004 |
Anti-IL-1a & IL1b Reference Antibody (Lutikizumab) |
IL-1b,IL-1a |
| 双抗 |
CHBA075 |
Anti-CD123 & CD3 Reference Antibody (Flotetuzumab) |
IL-3Ra / CD123,CD3 |
| 双抗 |
CHBA041 |
Anti-LILRB1 & LILRB2 Reference Antibody (Ngm707) |
LILRB2 / ILT4 / CD85d,LILRB1 / ILT2 / CD85j |
| 双抗 |
CHBA035 |
Anti-CD3e & Mesothelin & Serum Albumin Reference Antibody (Hpn536) |
Mesothelin,CD3e,Serum Albumin / SA / HSA |
| 双抗 |
CHBA055 |
Anti-PD-1 & PD-L1 Reference Antibody (Reozalimab) |
PDCD1 / PD-1 / CD279,B7-H1 / PD-L1 / CD274 |
| 双抗 |
CHBA014 |
Anti-CD47 & PD-1 Reference Antibody (Hx009） |
PDCD1 / PD-1 / CD279,CD47 |
| 双抗 |
CHBA044 |
Anti-LAG-3 & PD-1 Reference Antibody (Tobemstomig） |
PDCD1 / PD-1 / CD279,LAG3 / CD223 |
| 双抗 |
CHBA061 |
Anti-LAG-3 & PD-1 Reference Antibody (Tebotelimab) |
PDCD1 / PD-1 / CD279,LAG3 / CD223 |
| 双抗 |
CHBA062 |
Anti-LAG-3 & PD-1 Reference Antibody (Emb-02) |
PDCD1 / PD-1 / CD279,LAG3 / CD223 |
| 双抗 |
CHBA009 |
Anti-PD-1 & TIGIT Reference Antibody (Rilvegostomig） |
PDCD1 / PD-1 / CD279,TIGIT / VSIG9 / VSTM3 |
| 双抗 |
CHBA071 |
Anti-PD-1 & TIM-3 Reference Antibody (Lomvastomig) |
PDCD1 / PD-1 / CD279,TIM-3 / HAVCR2 / CD366 |
| 双抗 |
CHBA056 |
Anti-PD-1 & VEGF Reference Antibody (Ivonescimab) |
PDCD1 / PD-1 / CD279,VEGF |
| 双抗 |
CHBA010 |
Anti-BCMA & CD3 Reference Antibody (Elranatamab) |
TNFRSF17 / BCMA / CD269,CD3 |
| 双抗 |
CHBA016 |
Anti-BCMA & BCMA & CD3 Reference Antibody (TNB-383B) |
TNFRSF17 / BCMA / CD269,CD3 |
| 双抗 |
CHBA019 |
Anti-BCMA & CD3 Reference Antibody (Linvoseltamab) |
TNFRSF17 / BCMA / CD269,CD3 |
| 双抗 |
CHBA029 |
Anti-CD3 & BCMA Reference Antibody (Teclistamab) |
TNFRSF17 / BCMA / CD269,CD3 |
| 双抗 |
CHBA030 |
Anti-BCMA & CD3 Reference Antibody (Alnuctamab) |
TNFRSF17 / BCMA / CD269,CD3 |
| 双抗 |
CHBA040 |
Anti-BCMA & CD3 Reference Antibody (Emb-06) |
TNFRSF17 / BCMA / CD269,CD3 |
| 双抗 |
CHBA033 |
Anti-4-1BB & FAP Reference Antibody (RO7122290) |
TNFRSF9 / 4-1BB / CD137,FAP |
| 双抗 |
CHBA034 |
Anti-4-1BB & CD40 Reference Antibody (Gen1042) |
TNFRSF9 / 4-1BB / CD137,TNFRSF5 / CD40 |
| 双抗 |
CHBA059 |
Anti-4-1BB & TPBG/5t4 Reference Antibody (Apv-527) |
TNFRSF9 / 4-1BB / CD137,TPBG |
| 双抗 |
CHBA001 |
Anti-BAFF & IL-17A Reference Antibody (Tibulizumab) |
TNFSF13B / BAFF / CD257,IL-17 / IL-17A / CTLA-8 |
| 双抗 |
CHBA020 |
Anti-TNFalpha & IL-17 Reference Antibody (Remtolumab) |
TNFSF2 / TNFa,IL-17 / IL-17A / CTLA-8 |
| 双抗 |
CHBA043 |
Anti-IL-17 & TNF-alpha Reference Antibody (COVA322) |
TNFSF2 / TNFa,IL-17 / IL-17A / CTLA-8 |
| 双抗 |
CHBA046 |
Anti-TNF-alpha & HSA Reference Antibody (Ozoralizumab) |
TNFSF2 / TNFa,Serum Albumin / SA / HSA |
| 双抗 |
CHBA037 |
Anti-CD3 & TPBG Reference Antibody (Gen1044) |
TPBG,CD3 |
| 双抗 |
CHBA036 |
Anti-CD37 Reference Antibody (Gen3009) |
TSPAN26 / CD37 |
| 双抗 |
CHBA054 |
Anti-ANG2 & VEGFA Reference Antibody (Faricimab) |
VEGFA,ANGPT2 |
| 双抗 |
CHBA067 |
Anti-ANG2 & VEGFA Reference Antibody (Vanucizumab) |
VEGFA,ANGPT2 |